Inventiva S.A. ADR (IVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IVA | URGN | AVBP | ||
| Company | Inventiva S.A. ADR | Urogen Pharma Ltd | Arrivent Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.51 | 21.50 | 22.88 | ||
| High | 6.77 | 22.02 | 23.50 | ||
| Low | 6.44 | 20.76 | 22.49 | ||
| Latest | 6.75 | 21.07 | 22.99 | ||
| Change | +0.05 | -0.73 | -0.10 | ||
| % Change | +0.75% | -3.35% | -0.43% | ||
| Volume | 667,800 | 579,100 | 302,500 | ||
| 20-Day Average Volume | 471,035 | 700,665 | 481,305 | ||
| Previous Close | 6.70 | 21.80 | 23.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.33 | 20.88 | 22.46 | ||
| 20-Day Raw Stochastic | 65.82% | 59.49% | 51.60% | ||
| 20-Day Relative Strength | 62.64 | 49.34 | 54.28 | ||
| Weighted Alpha | +129.43 | +58.32 | -3.85 | ||
| Today's Opinion | 100% Buy | 24% Buy | 96% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 96% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.87% since 02/12/26 | +4.26% since 02/12/26 | +2.54% since 02/12/26 | ||
| Low | 5.95 on 02/17/26 | 19.45 on 02/17/26 | 22.13 on 02/13/26 | ||
| High | 6.77 on 02/20/26 | 22.50 on 02/19/26 | 23.66 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | +4.98% since 01/20/26 | +9.00% since 01/20/26 | +3.28% since 01/20/26 | ||
| Low | 5.71 on 02/06/26 | 18.13 on 01/21/26 | 20.00 on 02/11/26 | ||
| High | 7.29 on 01/26/26 | 22.50 on 02/19/26 | 26.00 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +73.97% since 11/20/25 | -15.18% since 11/20/25 | +14.61% since 11/20/25 | ||
| Low | 3.98 on 12/03/25 | 18.12 on 01/14/26 | 18.20 on 01/06/26 | ||
| High | 7.29 on 01/26/26 | 30.00 on 11/26/25 | 26.00 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +47.38% since 08/20/25 | +9.11% since 08/20/25 | +19.30% since 08/20/25 | ||
| Low | 3.55 on 11/13/25 | 15.86 on 10/10/25 | 17.00 on 11/03/25 | ||
| High | 7.98 on 10/28/25 | 30.00 on 11/26/25 | 26.00 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 985,169 | 986,265 | 949,050 | ||
| Shares Outstanding, K | 145,951 | 46,809 | 41,281 | ||
| Annual Sales | 15,930,000 | 90,400,000 | 0 | ||
| Annual Net Income | -199,340,000 | -126,870,000 | -80,490,000 | ||
| Last Quarter Sales | 65,000 | 27,480,000 | 0 | ||
| Last Quarter Net Income | -14,296,000 | -33,350,000 | -34,980,000 | ||
| 60-Month Beta | 0.72 | 1.32 | 1.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/20/21 | -0.69 on 11/06/25 | -0.83 on 11/10/25 | ||
| Latest Earnings Date | 03/25/26 | 03/09/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||